Delivery Order SPE2DB22D3004-SPE2DB25FPC32

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,379.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 2% 200 MG/10 ML 10ML, a medical product. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,547.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4559170113 - Lidocaine HCL 4% Solution 50ML, with a completion date of November 23, 2022. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,702.82 firm fixed-price delivery order is for the supply of 4% Lidocaine HCL Ampul, 5 ML. The contract has an ultimate completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $5,553.01 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565425592 - Lidocaine HCL 4% Solution 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024 and is a firm fixed price, no set-aside contract. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply critical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $2,824.37, is for the delivery of a specific medical product - Lidocaine HCL 2% 200 mg/10 mL. The contract is a firm fixed-price Delivery Order with a completion date of June 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of a lidocaine hydrochloride 4% solution. The $2,022.64 delivery order is a firm-fixed price contract with a completion date of May 31, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award, with an ID of SPE2DX15D2223|SPE2DX25F4DHA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,286,197 units of Lidocaine HCL 2% Luer-Jet 5ML, a pharmaceutical product. The contract has a ceiling value of $2,809.98 and a firm fixed-price pricing type. It is a delivery order with a completion date of November 1, 2024. Amerisourcebergen Drug Corp is a...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine HCL 2% 200 mg/10 ml, 10 ml vials. The contract, valued at $6,808.26, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) on February 28, 2024, with a completion date of February 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a specific pharmaceutical product - Lidocaine HCL 4% Solution 50ML. The contract award has a ceiling value of $1,095.78 and was issued as a Delivery Order. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,509.92, is for the delivery of 4567376999 - Lidocaine HCL 4% Solution 4ML. This is a firm-fixed-price contract with a completion date of February 26, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPC32
    Delivery Order

This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FPC32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 4% Solution 4ML, a medical product, with a ceiling value of $2,660.19. The contract is a Delivery Order under a Firm Fixed Price contract type, with a final completion date of January 15, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:06 AM